AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer

被引：7

作者：

Spirina, L. V. ^{[1
,2
]}

Avgustinovich, A. V. ^{[1
]}

Afanas'ev, S. G. ^{[1
]}

Kondakova, I. V. ^{[1
]}

Volkov, M. Yu. ^{[1
]}

Dobrodeev, A. Yu. ^{[1
]}

Boronkina, A. I. ^{[2
]}

机构：

[1] Tomsk Natl Res Med Ctr, Canc Res Inst, Tomsk, Russia

[2] Siberian State Med Univ, Minist Hlth Russian Federat, Tomsk, Russia

来源：

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2020年 / 170卷 / 01期

关键词：

gastric cancer; AKT; mTOR signaling cascade; PD; PD-L1; PD-L2; PATHWAY; AKT;

D O I：

10.1007/s10517-020-05007-0

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The peculiarities of gastric cancer development associated with the expression levels of components of the AKT/mTOR signaling cascade and PD, PD-L1, PD-L2 have not yet been identified. We revealed the fundamental changes in the expression AKT/mTOR and PD receptors and their ligands associated with dissemination of gastric cancer. An increase in the mRNA level of all components of this cascade was demonstrated. The expression of mTOR and AKT decreased against the background of enhanced expression of PTEN phosphatase. The increase in the expression of PD-1 receptors and PD-L1 and PD-L2 ligands was most pronounced in patients with distant metastases.

引用

页码：75 / 78

页数：4

共 50 条

[21] ANO9 regulates PD-L2 expression and binding ability to PD-1 in gastric cancer
Katsurahara, Keita
Shiozaki, Atsushi
Kosuga, Toshiyuki
Shimizu, Hiroki
Kudou, Michihiro
Arita, Tomohiro
Konishi, Hirotaka
Komatsu, Shuhei
Kubota, Takeshi
Fujiwara, Hitoshi
Okamoto, Kazuma
Kishimoto, Mitsuo
Konishi, Eiichi
Otsuji, Eigo
CANCER SCIENCE, 2021, 112 (03) : 1026 - 1037
[22] Divergent Expression of PD-1 as Challenges and Chances of Immunotherapy Targeting PD-1 or PD-L1 in Cancer
Huang, Haozhe
BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 55 - 69
[23] Prognostic significance of PD-L1 and PD-L2 in breast cancer
Baptista, Mauricio Z.
Sarian, Luis Otavio
Derchain, Sophie F. M.
Pinto, Glauce A.
Vassal, Jose
HUMAN PATHOLOGY, 2016, 47 (01) : 78 - 84
[24] PD-1 AND PD-L1 EXPRESSION ON THE PROGNOSIS OF OVARIAN CANCER
Li, R. P.
Li, W. Y.
Guo, Y. Z.
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (04) : 1161 - 1166
[25] Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer
Calles, Antonio
Liao, Xiaoyun
Sholl, Lynette M.
Rodig, Scott J.
Freeman, Gordon J.
Butaney, Mohit
Lydon, Christine
Dahlberg, Suzanne E.
Hodi, F. Stephen
Oxnard, Geoffrey R.
Jackman, David M.
Jaenne, Pasi A.
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) : 1726 - 1735
[26] PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer
Wu, Yanhua
Cao, Donghui
Qu, Limei
Cao, Xueyuan
Jia, Zhifang
Zhao, Tiancheng
Wang, Quan
Jiang, Jing
ONCOTARGET, 2017, 8 (38) : 64066 - 64082
[27] Evaluation of PD-L1, PD-L2, PD-1 and cytotoxic immune response in oral lichen planus
Costa, Nadia Lago
Goncalves, Julie Ane Maria
de Lima, Sara Lia Goncalves
de Arruda, Jose Alcides Almeida
Miranda, Ana Carolina Campos
Mesquita, Ricardo Alves
da Silveira, Ericka Janine Dantas
Batista, Aline Carvalho
ORAL DISEASES, 2020, 26 (06) : 1246 - 1254
[28] High-affinity PD-1 molecules deliver improved interaction with PD-L1 and PD-L2
Li, Yanyan
Liang, Zhaoduan
Tian, Ye
Cai, Wenxuan
Weng, Zhiming
Chen, Lin
Zhang, Huanling
Bao, Yifeng
Zheng, Hongjun
Zeng, Sihai
Bei, Chunhua
Li, Yi
CANCER SCIENCE, 2018, 109 (08): : 2435 - 2445
[29] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
Bai, Jie
Gao, Zhitao
Li, Xiang
Dong, Liang
Han, Weidong
Nie, Jing
ONCOTARGET, 2017, 8 (66) : 110693 - 110707
[30] Regulation of PD-1/PD-L1 Pathway in Cancer by Noncoding RNAs
Ding, Lei
Lu, Shengdi
Li, Yanli
PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 651 - 663

← 1 2 3 4 5 →